Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
Background: Budget impact analysis (BIA) is an economic assessment that estimates the financial consequences of adopting a new intervention. BIA is used to make informed reimbursement decisions, as a supplement to cost-effectiveness analyses (CEAs).Objectives: We systematically reviewed BIA studies...
Guardado en:
Autores principales: | Zejun Luo, Zhen Ruan, Dongning Yao, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0af68f6f1624bf5ba2cdb9e929b7fb9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion
por: Pedram Sendi, et al.
Publicado: (2021) -
Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use
por: Zuanji Liang, et al.
Publicado: (2021) -
Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study
por: Yue Ma, et al.
Publicado: (2021) -
The short-term associations of chronic obstructive pulmonary disease hospitalizations with meteorological factors and air pollutants in Southwest China: a time-series study
por: Meng Li, et al.
Publicado: (2021) -
CEA preoperatorio como factor pronóstico en cáncer de colon y recto: análisis de 532 pacientes
por: BANNURA C,GUILLERMO, et al.
Publicado: (2008)